ViroTact is developing a unique, quick and affordable test (ViroTact© – CoviTact©) to detect infection by COVID-19 by detecting the presence of an essential virus-encoded protease in a patient sample. NIZO contributes to the development of this assay by providing mechanistic understanding of the mode of action of the essential virus-encoded protease in order to optimize the specificity and sensitivity of the assay. Read more.